Irina Koffler | LifeSci Advisors |
Spiro Rombotis | President, CEO & Executive Director |
Paul McBarron | EVP, CFO, COO, Secretary & Executive Director |
Mark Kirschbaum | SVP & Chief Medical Officer |
Kevin DeGeeter | Oppenheimer |
Ahu Demir | Ladenburg Thalmann & Co. |
Jonathan Aschoff | ROTH Capital Partners |
Good afternoon, and welcome to the Cyclacel Pharmaceuticals First Quarter 2022 Results Conference Call and Webcast. [Operator Instructions]. Please note, today's call is being recorded. I would now like to turn the conference call over to the company.
Good afternoon, everyone, and thank you for joining today's conference call to discuss Cyclacel's Financial Results and Business Highlights for the first quarter of 2022.